GlassScriptPhysician profile
Rodney Biggs
NPI 1124400411
$2,280.23
in general payments reported to CMS, 2019-2025
25 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $498 · 2022: $861 · 2023: $511 · 2024: $83.77 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $319.77 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $262.81 | 2022-2023 | Seglentis |
| Novo Nordisk INC | $212.85 | 2021-2022 | |
| Radius Health, INC. | $131.50 | 2021-2022 | |
| Lundbeck LLC | $125.00 | 2021 | |
| Axsome Therapeutics, INC. | $125.00 | 2023 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $124.26 | 2025 | |
| Abbott Laboratories | $115.04 | 2022 | |
| Smith+Nephew, INC. | $108.46 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $103.85 | 2024-2025 | |
| Bioventus LLC | $89.21 | 2023-2025 | Durolane, Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $70.12 | 2022-2023 | Zilretta, Iovera, Exparel |
| Sanara Medtech INC. | $61.77 | 2023 | Celleraterx |
| Abbvie INC. | $60.92 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $56.31 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $54.26 | 2024-2025 | |
| Kci USA, INC. | $53.09 | 2022-2023 | Prevena |
| Stryker Corporation | $46.80 | 2021-2023 | Neptune |
| Kerecis Limited | $39.57 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Amgen INC. | $33.12 | 2021-2022 | |
| Organogenesis INC. | $29.92 | 2023 | Puraply |
| Solventum Corporation | $18.19 | 2025 | Prevena |
| Horizon Therapeutics Plc | $13.94 | 2021 | |
| Heron Therapeutics, INC. | $12.57 | 2021 | |
| Alon Medical Technology | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Biggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.